Fig. 1From: Overweight with HBV infection limited the efficacy of TACE in hepatocellular carcinoma by inhibiting the upregulated HMGB1The flowchart of this study. Cohort identification and inclusion/exclusion flow chart in this study. HCC = hepatocellular carcinoma; TACE = transarterial chemoembolization; HBV = hepatitis B virus; BMI = body mass indexBack to article page